Celldex Therapeutics, Inc. Interest and Other Income
Celldex Therapeutics, Inc. (CLDX) reported Interest and Other Income of $7.12 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2026-08-06
- Celldex Therapeutics, Inc. interest and other income for the quarter ending 2026-06-30 was $7.12M, a 1.89% decline year-over-year.
- Celldex Therapeutics, Inc. interest and other income for the quarter ending 2026-03-31 was $5.75M, a 35.70% decline year-over-year.
- Celldex Therapeutics, Inc. interest and other income for the quarter ending 2025-12-31 was $5.84M, a 34.68% decline year-over-year.
- Celldex Therapeutics, Inc. interest and other income for the quarter ending 2025-09-30 was $6.57M, a 34.30% decline year-over-year.
- Celldex Therapeutics, Inc. interest and other income for fiscal 2025 was $28.61M, a 23.12% decline from fiscal 2024.
- Celldex Therapeutics, Inc. interest and other income for fiscal 2024 was $37.22M, a 183.80% increase from fiscal 2023.
- Celldex Therapeutics, Inc. interest and other income for fiscal 2023 was $13.11M, a 350.77% increase from fiscal 2022.
- Celldex Therapeutics, Inc. interest and other income for fiscal 2022 was $2.91M, a 476.04% increase from fiscal 2021.
| Period end | Interest and Other Income 3 month | Interest and Other Income 6 month | Interest and Other Income 9 month | Interest and Other Income 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.12M 10-Q · filed 2026-08-06 | $12.87M 10-Q · filed 2026-08-06 | $18.71M derived: sum of 3 quarters · filed 2026-08-06 | $25.28M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $5.75M 10-Q · filed 2026-05-07 | $11.59M derived: sum of 2 quarters · filed 2026-05-07 | $18.16M derived: sum of 3 quarters · filed 2026-05-07 | $25.42M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $5.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $12.41M derived: sum of 2 quarters · filed 2026-02-25 | $19.67M derived: sum of 3 quarters · filed 2026-08-06 | $28.61M 10-K · filed 2026-02-25 |
| 2025-09-30 | $6.57M 10-Q · filed 2025-11-10 | $13.83M derived: sum of 2 quarters · filed 2026-08-06 | $22.77M 10-Q · filed 2025-11-10 | $31.71M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $7.26M 10-Q · filed 2026-08-06 | $16.20M 10-Q · filed 2026-08-06 | $25.14M derived: sum of 3 quarters · filed 2026-08-06 | $35.14M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $8.94M 10-Q · filed 2026-05-07 | $17.88M derived: sum of 2 quarters · filed 2026-05-07 | $27.88M derived: sum of 3 quarters · filed 2026-05-07 | $38.36M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $8.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $18.94M derived: sum of 2 quarters · filed 2026-02-25 | $29.41M derived: sum of 3 quarters · filed 2026-02-25 | $37.22M 10-K · filed 2026-02-25 |
| 2024-09-30 | $10.01M 10-Q · filed 2025-11-10 | $20.48M derived: sum of 2 quarters · filed 2025-11-10 | $28.28M 10-Q · filed 2025-11-10 | $32.60M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $10.47M 10-Q · filed 2025-08-07 | $18.27M 10-Q · filed 2025-08-07 | $22.60M derived: sum of 3 quarters · filed 2026-02-25 | $25.57M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $7.80M 10-Q · filed 2025-05-08 | $12.12M derived: sum of 2 quarters · filed 2026-02-25 | $15.10M derived: sum of 3 quarters · filed 2026-02-25 | $17.80M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $4.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $7.30M derived: sum of 2 quarters · filed 2026-02-25 | $10.00M derived: sum of 3 quarters · filed 2026-02-25 | $13.11M 10-K · filed 2026-02-25 |
| 2023-09-30 | $2.98M 10-Q · filed 2024-11-06 | $5.68M derived: sum of 2 quarters · filed 2024-11-06 | $8.79M 10-Q · filed 2024-11-06 | $10.19M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $2.70M 10-Q · filed 2024-08-08 | $5.81M 10-Q · filed 2024-08-08 | $7.21M derived: sum of 3 quarters · filed 2025-02-27 | $8.12M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $3.11M 10-Q · filed 2024-05-06 | $4.51M derived: sum of 2 quarters · filed 2025-02-27 | $5.42M derived: sum of 3 quarters · filed 2025-02-27 | $5.81M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.31M derived: sum of 2 quarters · filed 2025-02-27 | $2.70M derived: sum of 3 quarters · filed 2025-02-27 | $2.91M 10-K · filed 2025-02-27 |
| 2022-09-30 | $912.00K 10-Q · filed 2023-11-02 | $1.30M derived: sum of 2 quarters · filed 2023-11-02 | $1.51M 10-Q · filed 2023-11-02 | $1.70M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | $392.00K 10-Q · filed 2023-08-08 | $599.00K 10-Q · filed 2023-08-08 | $791.00K derived: sum of 3 quarters · filed 2024-02-26 | $936.00K derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | $207.00K 10-Q · filed 2023-05-04 | $399.00K derived: sum of 2 quarters · filed 2024-02-26 | $544.00K derived: sum of 3 quarters · filed 2024-02-26 | $611.00K derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | $192.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $337.00K derived: sum of 2 quarters · filed 2024-02-26 | $404.00K derived: sum of 3 quarters · filed 2024-02-26 | $505.00K 10-K · filed 2024-02-26 |
| 2021-09-30 | $145.00K 10-Q · filed 2022-11-09 | $212.00K derived: sum of 2 quarters · filed 2022-11-09 | $313.00K 10-Q · filed 2022-11-09 | $2.25M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $67.00K 10-Q · filed 2022-08-08 | $167.00K 10-Q · filed 2022-08-08 | $2.11M derived: sum of 3 quarters · filed 2023-02-28 | $2.23M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $101.00K 10-Q · filed 2022-05-05 | $2.04M derived: sum of 2 quarters · filed 2023-02-28 | $2.16M derived: sum of 3 quarters · filed 2023-02-28 | $2.27M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $2.06M derived: sum of 2 quarters · filed 2023-02-28 | $2.17M derived: sum of 3 quarters · filed 2023-02-28 | $2.41M 10-K · filed 2023-02-28 |
| 2020-09-30 | $118.00K 10-Q · filed 2021-11-09 | $224.00K derived: sum of 2 quarters · filed 2021-11-09 | $465.00K 10-Q · filed 2021-11-09 | $3.01M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $106.00K 10-Q · filed 2021-08-05 | $347.00K 10-Q · filed 2021-08-05 | $2.89M derived: sum of 3 quarters · filed 2022-02-28 | $3.32M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $242.00K 10-Q · filed 2021-05-06 | $2.78M derived: sum of 2 quarters · filed 2022-02-28 | $3.21M derived: sum of 3 quarters · filed 2022-02-28 | $3.69M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $2.97M derived: sum of 2 quarters · filed 2022-02-28 | $3.45M derived: sum of 3 quarters · filed 2022-02-28 | $4.15M 10-K · filed 2022-02-28 |
| 2019-09-30 | $431.00K 10-Q · filed 2020-11-05 | $909.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.61M 10-Q · filed 2020-11-05 | $4.33M derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-06-30 | $478.00K 10-Q · filed 2020-08-06 | $1.18M 10-Q · filed 2020-08-06 | $3.90M derived: sum of 3 quarters · filed 2021-03-29 | $4.42M derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-03-31 | $702.00K 10-Q · filed 2020-05-06 | $3.42M derived: sum of 2 quarters · filed 2021-03-29 | $3.94M derived: sum of 3 quarters · filed 2021-03-29 | $4.41M derived: sum of 4 quarters · filed 2021-03-29 |
| 2018-12-31 | $2.72M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $3.24M derived: sum of 2 quarters · filed 2021-03-29 | $3.71M derived: sum of 3 quarters · filed 2021-03-29 | $4.49M 10-K · filed 2021-03-29 |
| 2018-09-30 | $521.00K 10-Q · filed 2019-11-12 | $987.00K derived: sum of 2 quarters · filed 2019-11-12 | $1.77M 10-Q · filed 2019-11-12 | $4.37M derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-06-30 | $466.00K 10-Q · filed 2019-08-07 | $1.25M 10-Q · filed 2019-08-07 | $3.85M derived: sum of 3 quarters · filed 2020-03-26 | $4.25M derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-03-31 | $780.00K 10-Q · filed 2019-05-07 | $3.38M derived: sum of 2 quarters · filed 2020-03-26 | $3.78M derived: sum of 3 quarters · filed 2020-03-26 | $4.14M derived: sum of 4 quarters · filed 2020-03-26 |
| 2017-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $3.00M derived: sum of 2 quarters · filed 2020-03-26 | $3.36M derived: sum of 3 quarters · filed 2020-03-26 | $4.21M 10-K · filed 2020-03-26 |
| 2017-09-30 | $398.00K 10-Q · filed 2018-11-07 | $760.00K derived: sum of 2 quarters · filed 2018-11-07 | $1.61M 10-Q · filed 2018-11-07 | $4.16M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $362.00K 10-Q · filed 2018-08-08 | $1.21M 10-Q · filed 2018-08-08 | $3.76M derived: sum of 3 quarters · filed 2019-03-07 | $4.15M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | $851.00K 10-Q · filed 2018-05-10 | $3.40M derived: sum of 2 quarters · filed 2019-03-07 | $3.79M derived: sum of 3 quarters · filed 2019-03-07 | $4.21M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | $2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $2.94M derived: sum of 2 quarters · filed 2019-03-07 | $3.35M derived: sum of 3 quarters · filed 2019-03-07 | $4.39M 10-K · filed 2019-03-07 |
| 2016-09-30 | $395.00K 10-Q · filed 2017-11-07 | $809.00K derived: sum of 2 quarters · filed 2017-11-07 | $1.84M 10-Q · filed 2017-11-07 | $2.59M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | $414.00K 10-Q · filed 2017-08-08 | $1.45M 10-Q · filed 2017-08-08 | $2.20M derived: sum of 3 quarters · filed 2018-03-07 | $2.59M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-03-31 | $1.03M 10-Q · filed 2017-05-09 | $1.78M derived: sum of 2 quarters · filed 2018-03-07 | $2.18M derived: sum of 3 quarters · filed 2018-03-07 | $2.57M derived: sum of 4 quarters · filed 2018-03-07 |
| 2015-12-31 | $754.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $1.15M derived: sum of 2 quarters · filed 2018-03-07 | $1.54M derived: sum of 3 quarters · filed 2018-03-07 | $2.34M 10-K · filed 2018-03-07 |
| 2015-09-30 | $391.00K 10-Q · filed 2016-11-07 | $782.00K derived: sum of 2 quarters · filed 2016-11-07 | $1.59M 10-Q · filed 2016-11-07 | $1.82M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | $391.00K 10-Q · filed 2016-08-08 | $1.20M 10-Q · filed 2016-08-08 | $1.43M derived: sum of 3 quarters · filed 2017-03-14 | $3.69M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-03-31 | $807.00K 10-Q · filed 2016-05-05 | $1.04M derived: sum of 2 quarters · filed 2017-03-14 | $3.30M derived: sum of 3 quarters · filed 2017-03-14 | $3.57M derived: sum of 4 quarters · filed 2017-03-14 |
| 2014-12-31 | $229.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $2.49M derived: sum of 2 quarters · filed 2017-03-14 | $2.76M derived: sum of 3 quarters · filed 2017-03-14 | $4.35M 10-K · filed 2017-03-14 |
| 2014-09-30 | $2.26M 10-Q · filed 2015-11-05 | $2.54M derived: sum of 2 quarters · filed 2015-11-05 | $4.12M 10-Q · filed 2015-11-05 | $4.26M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $275.00K 10-Q · filed 2015-08-10 | $1.86M 10-Q · filed 2015-08-10 | $2.00M derived: sum of 3 quarters · filed 2016-02-25 | $2.14M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $1.59M 10-Q · filed 2015-04-29 | $1.72M derived: sum of 2 quarters · filed 2016-02-25 | $1.86M derived: sum of 3 quarters · filed 2016-02-25 | $2.03M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $137.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-02-25 | $279.00K derived: sum of 2 quarters · filed 2016-02-25 | $440.00K derived: sum of 3 quarters · filed 2016-02-25 | $819.00K 10-K/A · filed 2016-02-25 |
| 2013-09-30 | $142.00K 10-Q · filed 2014-11-05 | $303.00K derived: sum of 2 quarters · filed 2014-11-05 | $682.00K 10-Q · filed 2014-11-05 | $776.00K derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $161.00K 10-Q · filed 2014-08-07 | $540.00K 10-Q · filed 2014-08-07 | $634.00K derived: sum of 3 quarters · filed 2015-02-24 | $739.00K derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $379.00K 10-Q · filed 2014-05-01 | $473.00K derived: sum of 2 quarters · filed 2015-02-24 | $578.00K derived: sum of 3 quarters · filed 2015-02-24 | $704.00K derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | $94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $199.00K derived: sum of 2 quarters · filed 2015-02-24 | $325.00K derived: sum of 3 quarters · filed 2015-02-24 | $530.00K 10-K · filed 2015-02-24 |
| 2012-09-30 | $105.00K 10-Q · filed 2013-11-08 | $231.00K derived: sum of 2 quarters · filed 2013-11-08 | $436.00K 10-Q · filed 2013-11-08 | |
| 2012-06-30 | $126.00K 10-Q · filed 2013-08-06 | $331.00K 10-Q · filed 2013-08-06 | ||
| 2012-03-31 | $205.00K 10-Q · filed 2013-05-03 | |||
| 2011-12-31 | $396.00K 10-K · filed 2014-03-03 | |||
| 2010-12-31 | $5.26M 10-K · filed 2013-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |